Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An updated patent review of VEGFR-2 inhibitors (2017-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 14, 2021 Category: Drugs & Pharmacology Authors: Thoraya A. Farghaly Wedian A. Al-Hasani Hanan Gaber Abdulwahab Source Type: research

A patent review of mTOR inhibitors for cancer therapy (2011 –2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 11, 2021 Category: Drugs & Pharmacology Authors: Han-Yue Qiu Peng-Fei Wang Min Zhang Source Type: research

Discerning the promising binding sites of S100/calgranulins and their therapeutic potential in atherosclerosis
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 10, 2021 Category: Drugs & Pharmacology Authors: Harbinder Singh Vikrant Rai Devendra K Agrawal Source Type: research

Ferroportin-inhibitor salt: patent evaluation WO2018192973
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 8, 2021 Category: Drugs & Pharmacology Authors: Snehal Kadam Megha Khaitan Paromita Banerjee Anita Mandhare Source Type: research

Avoiding hindsight in non-obviousness determination: case law review of pharmaceutical patents and guidance from the KSR v Teleflex decision
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 26, 2021 Category: Drugs & Pharmacology Authors: Sivakami Dhulap M.G Kulkarni Source Type: research

A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 21, 2021 Category: Drugs & Pharmacology Authors: Bel én Martinez-Gualda Dominique Schols Steven De Jonghe Source Type: research

Inhibitors of immuno-oncology target HPK1 – a patent review (2016 to 2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 20, 2021 Category: Drugs & Pharmacology Authors: Ian D Linney Neelu Kaila Source Type: research

An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 20, 2021 Category: Drugs & Pharmacology Authors: Aaftaab Sethi Swetha Sanam Ravi Alvala Mallika Alvala Source Type: research

Metal organic frameworks (MOFs) with therapeutic and biomedical applications: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 19, 2021 Category: Drugs & Pharmacology Authors: Jos é Marcos Teixeira de Alencar Filho Pedrita Alves Sampaio Iure Silva de Carvalho Ademar Rocha da Silva Emanuella Chiara Valen ça Pereira Isabela Araujo e Amariz Rodolfo Hideki Vicente Nishimura Edig ênia Cavalcante da Cruz Araújo Pedro Jos é Rolim Source Type: research

Targeting the TGF- β signaling pathway for fibrosis therapy: a patent review (2015–2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 17, 2021 Category: Drugs & Pharmacology Authors: Xuanyi Li Ziang Ding Zixuan Wu Yinqiu Xu Hequan Yao Kejiang Lin Source Type: research

Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016 –2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 16, 2021 Category: Drugs & Pharmacology Authors: Dima A. Sabbah Rima Hajjo Sanaa K. Bardaweel Haizhen A. Zhong Source Type: research

Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 13, 2021 Category: Drugs & Pharmacology Authors: Alessio Nocentini Clemente Capasso Claudiu T. Supuran Source Type: research

GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 10, 2021 Category: Drugs & Pharmacology Authors: Huilan Li Yuanying Fang Shuchun Guo Zunhua Yang Source Type: research

An updated patent review of Akt inhibitors (2016-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 2, 2021 Category: Drugs & Pharmacology Authors: Yu Guo Yizhen Jin Bingxue Qu Yu Zhang Jinxin Che Xiaowu Dong Source Type: research

A patent review of topoisomerase I inhibitors (2016 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 29, 2021 Category: Drugs & Pharmacology Authors: Asier Selas Endika Martin-Encinas Maria Fuertes Carme Masdeu Gloria Rubiales Francisco Palacios Concepci ón Alonso Source Type: research